Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity

V. Bartáková, K. Chalásová, L. Pácal, V. Ťápalová, J. Máchal, P. Janků, K. Kaňková

. 2024 ; 13 (5) : . [pub] 20240222

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013145

Grantová podpora
LX22NPO5104 National Institute for Research of Metabolic and Cardiovascular Diseases

Background: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. Methods: A cross-sectional observational study comprised n = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. Results: MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (p = 0.01 resp. p = 0.0004, chi-square). Conclusions: The presence of MS in GDM patients is a statistically significant risk factor (p = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013145
003      
CZ-PrNML
005      
20240726151533.0
007      
ta
008      
240723s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm13051260 $2 doi
035    __
$a (PubMed)38592122
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bartáková, Vendula $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000250474752
245    10
$a Metabolic Syndrome Prevalence in Women with Gestational Diabetes Mellitus in the Second Trimester of Gravidity / $c V. Bartáková, K. Chalásová, L. Pácal, V. Ťápalová, J. Máchal, P. Janků, K. Kaňková
520    9_
$a Background: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. Methods: A cross-sectional observational study comprised n = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. Results: MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (p = 0.01 resp. p = 0.0004, chi-square). Conclusions: The presence of MS in GDM patients is a statistically significant risk factor (p = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chalásová, Katarína $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Pácal, Lukáš $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000311187424
700    1_
$a Ťápalová, Veronika $u Department of Obstetrics and Gynaecology, University Hospital Brno, 66263 Brno, Czech Republic
700    1_
$a Máchal, Jan $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000282923145
700    1_
$a Janků, Petr $u Department of Obstetrics and Gynaecology, University Hospital Brno, 66263 Brno, Czech Republic
700    1_
$a Kaňková, Kateřina $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 13, č. 5 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38592122 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151526 $b ABA008
999    __
$a ok $b bmc $g 2125619 $s 1225008
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 13 $c 5 $e 20240222 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace